304 related articles for article (PubMed ID: 16439306)
1. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
van Kempen LC; Leenders WP
Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
[TBL] [Abstract][Full Text] [Related]
2. Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.
Goto H; Nishioka Y
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286323
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in spontaneous tumors and implications for comparative tumor biology.
Benazzi C; Al-Dissi A; Chau CH; Figg WD; Sarli G; de Oliveira JT; Gärtner F
ScientificWorldJournal; 2014; 2014():919570. PubMed ID: 24563633
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.
El-Kenawi AE; El-Remessy AB
Br J Pharmacol; 2013 Oct; 170(4):712-29. PubMed ID: 23962094
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for anti-angiogenic therapy in cancer.
Wehland M; Bauer J; Magnusson NE; Infanger M; Grimm D
Int J Mol Sci; 2013 Apr; 14(5):9338-64. PubMed ID: 23629668
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis as a therapeutic target in cancer.
Kumaran G; Clamp AR; Jayson GC
Clin Med (Lond); 2008 Aug; 8(4):455-8. PubMed ID: 18724620
[No Abstract] [Full Text] [Related]
7. Vascular normalisation as the stepping stone into tumour microenvironment transformation.
Magnussen AL; Mills IG
Br J Cancer; 2021 Aug; 125(3):324-336. PubMed ID: 33828258
[TBL] [Abstract][Full Text] [Related]
8. Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.
Abdalla AME; Xiao L; Ullah MW; Yu M; Ouyang C; Yang G
Theranostics; 2018; 8(2):533-548. PubMed ID: 29290825
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.
Le CP; Karnezis T; Achen MG; Stacker SA; Sloan EK
Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):409-25. PubMed ID: 24267548
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils: key mediators of tumour angiogenesis.
Tazzyman S; Lewis CE; Murdoch C
Int J Exp Pathol; 2009 Jun; 90(3):222-31. PubMed ID: 19563607
[TBL] [Abstract][Full Text] [Related]
11. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies.
Hida K; Hida Y; Shindoh M
Cancer Sci; 2008 Mar; 99(3):459-66. PubMed ID: 18167133
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities.
Mabeta P; Hull R; Dlamini Z
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052495
[TBL] [Abstract][Full Text] [Related]
13. Oligosaccharides as anti-angiogenic agents.
Cole CL; Jayson GC
Expert Opin Biol Ther; 2008 Mar; 8(3):351-62. PubMed ID: 18294105
[TBL] [Abstract][Full Text] [Related]
14. Tumour Angiogenesis and Angiogenic Inhibitors: A Review.
Yadav L; Puri N; Rastogi V; Satpute P; Sharma V
J Clin Diagn Res; 2015 Jun; 9(6):XE01-XE05. PubMed ID: 26266204
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies.
Yang Z; Deng W; Zhang X; An Y; Liu Y; Yao H; Zhang Z
Front Oncol; 2021; 11():789330. PubMed ID: 35083147
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment.
Moon HH; Park JE; Kim YH; Kim JH; Kim HS
J Neurooncol; 2022 May; 157(3):405-415. PubMed ID: 35275335
[TBL] [Abstract][Full Text] [Related]
17. Divergent roles of Plexin D1 in cancer.
Vivekanadhan S; Mukhopadhyay D
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):103-110. PubMed ID: 31152824
[TBL] [Abstract][Full Text] [Related]
18. In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued.
van Lith SA; Roodink I; Verhoeff JJ; Mäkinen PI; Lappalainen JP; Ylä-Herttuala S; Raats J; van Wijk E; Roepman R; Letteboer SJ; Verrijp K; Leenders WP
Oncotarget; 2016 Nov; 7(44):71594-71607. PubMed ID: 27689404
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1-Jagged1-KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis.
Chen HF; Wu KJ
Stem Cells Int; 2016; 2016():6439864. PubMed ID: 26823670
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics.
Upreti M; Jamshidi-Parsian A; Koonce NA; Webber JS; Sharma SK; Asea AA; Mader MJ; Griffin RJ
Transl Oncol; 2011 Dec; 4(6):365-76. PubMed ID: 22191001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
